Bangalore

Teva is a global pharmaceutical leader and the world’s largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide.  Our employees are at the core of our success, with colleagues in over 80 countries delivering the world’s largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we’ve built a promising pipeline centered around our core therapeutic areas.

Post : Clinical Research Scientist

CBCC Global Research is an oncology and medical device focused contract research organization serving a wide spectrum of clinical research services including Phase II-IV clinical trials services, medical writing and HEOR related writing, ECG & image core lab services, post marketing registry trials to the Bio-Pharmaceutical, Medical device, and Diagnostics companies. Our close association with our medical advisory board and research communities helps us decode the intricacies of clinical trials targeted at specific therapeutic areas.

National Institute of Unani Medicine (NIUM) Bangalore is as an autonomous organization under the Ministry of AYUSH, Government of India working since 2004.

Forest Research Institute (FRI), Dehra Dun made a humble beginning as Forest School established in 1878. Initially named as Imperial Forest Research Institute, FRI came into being in 1906.  Later renamed as Forest Research Institute and Colleges, with a number of centres located at different places all over the country administering research as well as training of Forest Officers and Forest Rangers.  After reorganization of Forestry Research in the country and creation of Indian Council of Forestry Research and Education (ICFRE) in 1988, the training and research centres were given an independent status of institutes. Forest Research Institute, now one of the institutes under ICFRE, was conferred the status of Deemed University in December 1991 on the recommendations of the UGC, Ministry of Human Resource Development, Government of India.

Quintiles and IMS Health have come together to become IQVIA, The Human Data Science Company. Inspired by the industry we help, IQVIA commits to providing solutions that enable life sciences companies to innovate with confidence, maximize their opportunities and ultimately drive human health outcomes forward.

Post : Clinical Data Specialist/Sr CDC

Thomson Reuters is the leading source of intelligent information for the world's businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster.

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products).

Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.  Each day, our employees around the world work together for patients – it drives everything we do.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
P.Mounika*, Sanjit, Abhishek pandey, Dilraj Yadav
Gautham College of Pharmacy,
Bangalore – 560032

ABSTRACT
Objective: The objective of the present study was to develop Bilayered tablets of Nifedipine and atenolol. Bilayered tablet contains two layers. We can formulate first layer into immediate release and second layer into sustained release for desired action. Nifedipine have half-life 2hrs make the drug suitable for immediate release. Atenolol have half-life 6-7hrs make the drug suitable for sustained release.
Methods: In this formulation using super disintegrants for immediate release, acacia and ethyl cellulose as a polymers for sustained release. Tablets were prepared by wet granulation method. In this study Bilayered tablets of Nifedipine and Atenolol tablets were evaluated for weight variation, hardness, thickness, drug content and In-vitro studies.
Results: Bi-layer tablet is suitable for sequential release of two drugs in combination, separate to incompatible substances and also for immediate release as initial dose and sustained release as maintenance dose. In Immediate release formulation, IR-F-3 formulation gives 98% release within 15min. For sustained effect SR-F-3, SR-F-1 gives 98% release within 8-9hrs. SR-F-2 gives 99% release within 10-11hrs for a longer period of time.
Conclusion: The combination of IF-3 and SR-F-2 suitable for formulation. This formulation is used for Bilayered tablet to combine with sustained released tablet. The evaluation parameters were estimated.